We report two patients who developed a severe discontinuation (withdrawal) reaction following stoppage of paroxetine and venlafaxine, respectively. Neurological symptoms were prominent and neither patient could walk unaided. Both patients feared they had suffered a ‘stroke’ and arranged an emergency medical consultation. One patient was correctly diagnosed, the antidepressant was recommenced and symptoms resolved within 24 h. Failure to recognize the reaction resulted in the other patient being referred to a neurologist, undergoing a computed tomography brain scan and an electroencephalogram and remaining symptomatic for over 8 weeks. Relevant pharmacological issues are discussed. The cases illustrate the importance of patients and clinicians being familiar with antidepressant discontinuation symptoms.
Australian Adverse Drug Reactions Committee (1996) SSRI's and withdrawal syndrome. Austr Adv Drug React Bull15: 3-3
2.
Coupland N J, Bell C J, Potokar J P (1996) Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol16: 356–362
3.
Drug and Therapeutics Bulletin (1999) Withdrawing patients from antidepressants. Drug Therapeut Bull37: 49–52
4.
Einbinder E (1995) Fluoxetine withdrawal?Am J Psychiatry152: 1253-1253
5.
Fava G A, Grandi S (1995) Withdrawal syndromes after paroxetine and sertraline discontinuation. J Clin Psychopharmacol15: 374–375
6.
Fava M, Mulroy R, Alpert, J, Nierenberg A A, Rosenbaum J F (1997) Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry154: 1760–1762
7.
Frost L, Lal S (1995) Shock-like sensations after discontinuation of selective serotonin reuptake inhibitor (letter). Am J Psychiatry152: 810-810
8.
Giakas W L, Davis S M (1997) Intractable withdrawal from venlafaxine treated with fluoxetine. Psychiatr Annals27: 85–92
9.
Haddad P (1998) The SSRI discontinuation syndrome. J Psychopharmacol12: 305–313
10.
Haddad P, Tylee A, Young A (1999) P137: general practitioners' (GPs) knowledge of antidepressant discontinuation symptoms (abstract). J Psychopharmacol13: (Suppl. A): A44-A44
11.
Hughes M S, Lessell S (1990) Trazodone-induced palinopsia. Arch Ophthalmol108: 399–400
12.
Jacobs B L, Fornal C A (1993) 5HT and motor control: a hypothesis. Trends Neurosci16: 346–352
13.
Kraus R P (1996) Visual ‘trails’ with nefazodone treatment (letter)Am J Psychiatry153: 1365–1366
14.
Lauterbach E C, Abdelhamid A, Annandale J B (2000) Posthallucinogen-like visual illusions (palinopsia) with risperidone in a patient without previous hallucinogen exposure: possible relation to serotonin 5HT2a receptor blockade. Pharmacopsychiatry33: 38–41
15.
Lejoyeux M, Ades J, Mourad I, Solomon J, Dilsaver S (1996) Antidepressant withdrawal syndrome. CNS Drugs5: 278–292
16.
Michelson D, Fava M, Amsterdam J, Apter J, Londborg P, Tamura R, Tepner R G (2000) Interruption of selective serotonin reuptake inhibitor treatment: double-blind, placebo-controlled trial. Br J Psychiatry176: 363–368
17.
Murphy S M, Tyrer P (1991) A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiatry158: 511–516
18.
Price J S, Waller P C, Wood S M, Mackay A V P (1996) A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors, including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol42: 757–763
19.
Rauch S L, O'sullivan R L, Jenike M A (1996) Open treatment of obsessive-compulsive disorder with venlafaxine: a series of 10 cases (letter). J Clin Psychopharmacol16: 81–84
20.
Rosenbaum J F, Fava M, Hoog S L, Ascroft R C, Krebs W B (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomised clinical trial. Biol Psychiatry44: 77–87
21.
Rosenstock H A (1996). Sertraline withdrawal in two brothers: a case report. Int Clin Psychopharmacol11: 58–59
22.
Taylor D, McConnell D, McConnell H, Abel K, Kerwin R (1999) The Bethlem & Maudsley NHS Trust prescribing guidelines, 5th edn.Martin Dunitz, London
23.
Waterhouse B D, Azizi S A, Burne R A, Woodward D J (1990) Modulation of rate cortical area 17 neuronal responses to moving visual stimuli during norepinephrine and serotonin microiontophoresis. Brain Res514: 276–292
